Trial With HuMax-CD4 in Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate and a TNF-alpha Blocker
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether HuMax-CD4 is effective in the treatment of
active rheumatoid arthritis in patients who have failed treatment with Methotrexate and at
least one TNF-alpha blocking agent.